American Physicians Service Group Inc (NASDAQ:AMPH) Sentiment Dropped in Q2 2018 to 1.11

American Physicians Service Group Inc’s Sentiment

“Big money sentiment for American Physicians Service Group Inc (NASDAQ:AMPH) in 2018 Q2 decreased to 1.11, according to SEC filings. That’s down -0.34, from 2018Q1’s 1.45. 50 investment professionals increased or opened new equity positions, while 45 cut down and sold their equity positions in American Physicians Service Group Inc so the sentiment dived. Funds own 19.80 million shares, down from 20.28 million shares in 2018Q1. Funds holding American Physicians Service Group Inc in top 10 was flat from 0 to 0 for the same number . In total 11 funds closed positions, 34 reduced and 35 increased. Also 15 funds bought new American Physicians Service Group Inc stakes.

Biggest American Physicians Service Group Inc Investors

As of 2018 Q2 Cortina Asset Management Llc has 0.28% invested in American Physicians Service Group Inc. American Physicians Service Group Inc’s shareholder Argent Capital Management Llc owns 235,775 shares as of 2018 Q2. Moreover, Federated Investors Inc Pa reported 1.28 million shares in American Physicians Service Group Inc equivalent to 0.06% of its portfolio. The New York-based fund Rothschild Asset Management Inc have invested about 0.05% of the active investment manager’s stock portfolio in American Physicians Service Group Inc. The New York-based fund Engineers Gate Manager Lp looks positive on American Physicians Service Group Inc, having 25,333 shares.

Amphastar Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development, manufacture, marketing, and sale of generic and proprietary injectable, inhalation, and intranasal products.The company has $1.01 billion market cap. It operates in two divisions, Finished Pharmaceutical Products and Active Pharmaceutical Ingredients.Last it reported negative earnings. The companyÂ’s product portfolio comprises enoxaparin, a low molecular weight heparin that is used as an anticoagulant for prevention and treatment of deep vein thrombosis; naloxone for treating opioid overdose; Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency; Amphadase, a bovine-sourced hyaluronidase injection for the dispersion and absorption of other injected drugs; and lidocaine jelly, a local anesthetic product for urological procedures.

The stock increased 1.24% or $0.27 during the last trading session, hitting $21.99.Amphastar Pharmaceuticals, Inc. has 248,433 shares volume, 15.61% up from normal. AMPH is uptrending and has moved 17.25% since December 8, 2017. The stock outperformed the S&P 500 by 1.63%.

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)’s quarterly earnings will be announced on March, 11., according to Zacks. Analysts expect change of 10.00 % or $0.01 from previous year’s $0.1 EPS compared to current’s $0.11 EPS. If AMPH’s EPS is $0.11 the profit will hit $5.07 million for 49.98 P/E. Wall Street now sees -8.33 % negative EPS growth despite Amphastar Pharmaceuticals, Inc. last quarter’s EPS of $0.12.

Cubist Systematic Strategies Ltd Com invested in 19,324 shs or 0.01% of the stock. 14,596 were reported by State Teachers Retirement System. Moreover, Voya Inv Management Limited has 0% invested in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH). Gsa Cap Prtnrs Llp owns 0.03% invested in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) for 33,000 shs. Tiaa Cref Ltd Liability stated it has 0% of its capital in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH). Invesco Limited reported 0% in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH). Bnp Paribas Arbitrage has invested 0% in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH). Swiss Bancorp has 0% invested in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH). Credit Suisse Ag holds 0% or 47,844 shs. 173,999 are held by Nordea Investment Mngmt Ab. Ubs Asset Mgmt Americas Inc has 297,488 shs. Ameritas Inv Prtn, Nebraska-based fund reported 3,073 shs. 1.28 million are owned by Federated Invsts Inc Pa. Barclays Public Ltd Company holds 0% of its capital in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) for 18,289 shs. Boston Ltd Liability Corporation owns 0.02% invested in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) for 41,948 shs.

For more Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) news brought out recently go to: Streetinsider.com, Seekingalpha.com, Seekingalpha.com, Globenewswire.com or Seekingalpha.com. The titles are as follows: “Amphastar Pharma (AMPH) on Watch Ahead of ’60 Minutes’ Reports on Naloxone – StreetInsider.com” brought out on November 16, 2018, “FDA OKs first non-opioid treatment for opioid withdrawal – Seeking Alpha” on May 16, 2018, “Without A Paddle: Amphastar – Seeking Alpha” with a publish date: March 15, 2017, “Amphastar Announces Final Judgment in the Patent Litigation against Momenta Pharmaceuticals, Inc. and Sandoz Inc. – GlobeNewswire” and the last “Apple suppliers, chips drop on Cirrus cut – Seeking Alpha” with publication date: December 04, 2018.

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.